A team of scientists at the Helmholtz Institute for RNA-based Infection Research (HIRI) in Würzburg and the University of ...

Human immunodeficiency virus type 1 (HIV-1) targets important cells of our immune system, making infected individuals more ...

Scientists have unveiled insights into how HIV-1, the virus responsible for AIDS, skillfully hijacks cellular machinery for its own survival. By dissecting the molecular interplay between the virus ...

A compound with the unpresuming designation of EBC-46 has made a splash in recent years for its cancer-fighting prowess. Now ...

Nov. 25, 2024 — A new study reveals significant progress in the global fight against HIV/AIDS ... By targeting infected cells in the brain, drug may clear virus ... Proof-of-Concept Study ...

People usually misinterpret HIV and AIDS ... T cells, are essential for immunological activity. The T-helper cells lose their ability to protect the body from infections as a result of the ...

CLAIM: HIV is part of the composition of COVID-19 vaccinesFACT: False. An experimental vaccine developed by Professor Keith ...

Based on this evidence, First Check determines that this viral video deceptively combines footage to falsely imply COVID ...

A unique reaction in which antibodies bind to other antibodies may help scientists at Scripps Research better understand how ...

Another important discovery was an intricate RNA structure near the critical “frameshift site” in the viral genome. This frameshift site is essential for the virus to produce the correct ...

Scientists at Duke University's Human Vaccine Institute have made a significant advance in the quest for an HIV vaccine.

Hopkins said that lenacapavir was expected to be reviewed by the U.S. Food and Drug Administration in 2025, with the potential to dramatically reduce HIV infection. "This will be a critical next step ...